QA/AI & ML Compliance Services

Where Quality Governance Meets Digital Compliance

Person typing on laptop with overlays for AI and ethics

The rapid evolution of artificial intelligence, automation, and digital systems is reshaping regulated industries. ProPharma's QA/AI & ML Compliance Services bridge the gap between innovation and compliance, providing strategic, technical, and regulatory expertise to help you confidently adopt AI and digital technologies, while maintaining GxP integrity and global regulatory alignment.

Empowering Life Science Organizations to Govern Artificial Intelligence (AI) System Compliance Responsibly in the Digital Era.

Globally integrate compliance with AI, digital technologies, and data-driven systems with confidence, Ensuring compliance, validation, and governance are built into every step of the technology-enabled journey.

Connection

AI Strategy Development, Readiness & Implementation

Adverse event intake icon

AI Validation, GxP Compliance & Governance

Signal management icon

Data Integrity (DI) Compliance Assessments

Pharmacovigilance

Cybersecurity Readiness Audits (GxP Focused)

Business professionals collaborating

ProPharma is Your Partner for AI-Driven Quality and Compliance Excellence, delivering:

Regulatory Expertise: Experience with FDA, EMA, MHRA, PMDA, and Health Canada expectations.

Proven AI & MReadiness Frameworks: Designed for scalable, compliant adoption.

Cross-Functional Expertise: Blending QA, data science, IT, and regulatory insights.

End-to-End Support: From strategy and validation to governance and audit readiness.

Comprehensive Support Across Your AI & ML Compliance Journey

Quality & Compliance Interconnected services are designed to ensure compliant, validated, and high-performing digital ecosystems

AI Strategy Development, Readiness & Implementation

Strengthening the foundation for AI success through structured readiness, governance, and implementation support that aligns with business and regulatory objectives.

  • Supporting clients on AI adoption and process enhancement
  • Enabling faster, smarter decision-making through integrated data and automation
  • Building internal AI capability and readiness
  • Proactively managing compliance and regulatory expectations
  • AI Readiness & Maturity Assessment
  • Digital Blueprint Development & Implementation
  • High-Impact AI Opportunity Identification
  • AI Partnership & Vendor Selection Support
  • AI Implementation Support (Business Process Optimization, OCM)
  • Governance & Performance Monitoring Frameworks
  • AI Compliance & Validation Plan

AI Validation, GxP Compliance & Governance

Ensure your AI/ML tools and algorithms meet stringent GxP, EMA, and FDA regulatory expectations through structured validation and compliance governance.

  • Validation of AI/ML applications in GxP processes (Manufacturing, QC, Clinical, etc.)
  • Assessment of algorithm training data integrity, bias, and traceability
  • Regulatory alignment verification for AI/ML systems in development and manufacturing
  • Validation Protocols & Reports
  • Algorithm Risk Assessments
  • AI/ML Lifecycle SOPs
  • Compliance Roadmaps for AI Use Cases

Data Integrity (DI) Compliance Assessments

Safeguard data trustworthiness and compliance during your digital transformation. Our DI experts assess, align compliance, and enhance your data integrity practices across systems and operations.

  • End-to-end DI audits for digital systems and applications
  • Evaluation of ALCOA+ principles, system controls, audit trails, backup/recovery
  • Map gaps vs. FDA/EMA DI guidelines and best practices
  • Development of upgrade and remediation strategies
  • Current-State DI Maturity Scorecard
  • Gap Analysis & Risk Matrix
  • Prioritized Remediation Plan
  • Updated DI SOPs
  • Support for Remediation Execution

Cybersecurity Readiness Audits (GxP Focused)

Identify and mitigate cybersecurity risks in GxP-critical digital systems to protect data integrity, ensure operational continuity, and align with global regulatory expectations.

  • Assessment of GxP digital systems (eQMS, eTMF, LIMS, MES, SCADA)
  • Evaluation of vulnerabilities and data protection measures
  • Cybersecurity Audit Report
  • GxP-Specific Cyber Risk Remediation Plan

QA/AI & ML Compliance Services

Partner with us for expert digital compliance and quality solutions. Contact ProPharma today to learn how we can support your organization’s Artificial Intelligence governance and Quality Assurance needs.

News & Insights

Understanding FDA Requirements for Medical Information Services in the US

December 22, 2025

Understanding FDA Requirements for Medical Information Services in the US

Learn about FDA requirements for medical information services in the US and how MI teams ensure compliance and protect public health through proper reporting and documentation practices.

Annex 11 2011 Version vs. Annex 11 2025 Draft Version: What are the Differences and Enhancements?

December 15, 2025

Annex 11 2011 Version vs. Annex 11 2025 Draft Version: What are the Differences ...

Discover the key differences and enhancements between Annex 11 2011 and the 2025 draft version for computerised systems in GMP-regulated environments.

Rescuing a Struggling PV Program: Warning Signs, Root Causes, and What to Do Next

November 20, 2025

Rescuing a Struggling PV Program: Warning Signs, Root Causes, and What to Do Nex...

Learn how to identify the warning signs of a failing pharmacovigilance vendor and navigate the rescue process to ensure program success.

ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

December 4, 2025

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

ProPharma taps Daniel Ryan as President of Clinical Research Solutions, strengthening its clinical trial management leadership and expanding its FSP Solutions.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Overcoming Operational Hurdles in a High-Stakes Stroke Trial - ProPharma

December 15, 2025

Overcoming Operational Hurdles in a High-Stakes Stroke Trial

Argenica Therapeutics’ Phase 2 acute ischaemic stroke trial faced the challenges of unpredictable patient presentation, narrow treatment windows, and demanding emergency care environments. This...

Article Functional Service Provider: An Emerging Paradigm in Clinical Trial Management - ProPharma

November 24, 2025

Functional Service Provider: An Emerging Paradigm in Clinical Trial Management

As biopharma and device companies face workforce reductions, global site expansion, and increasingly intricate clinical protocols, traditional outsourcing models often fall short. The cost of...

Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Cracking the Code – Successfully Delivering a Technology Transfer Project

January 20, 2026

Cracking the Code – Successfully Delivering a Technology Transfer Project

In this power-packed webinar, we’ll demystify technology transfer and show why it’s one of the most strategic and risk-sensitive steps in pharmaceutical and biotech operations. You’ll uncover insider...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

News & Insights

Understanding FDA Requirements for Medical Information Services in the US

December 22, 2025

Understanding FDA Requirements for Medical Information Services in the US

Learn about FDA requirements for medical information services in the US and how MI teams ensure compliance and protect public health through proper reporting and documentation practices.

Annex 11 2011 Version vs. Annex 11 2025 Draft Version: What are the Differences and Enhancements?

December 15, 2025

Annex 11 2011 Version vs. Annex 11 2025 Draft Version: What are the Differences ...

Discover the key differences and enhancements between Annex 11 2011 and the 2025 draft version for computerised systems in GMP-regulated environments.

Rescuing a Struggling PV Program: Warning Signs, Root Causes, and What to Do Next

November 20, 2025

Rescuing a Struggling PV Program: Warning Signs, Root Causes, and What to Do Nex...

Learn how to identify the warning signs of a failing pharmacovigilance vendor and navigate the rescue process to ensure program success.

Previous Post Arrow Next Post Arrow
ProPharma Expands Operations with New Office in Hyderabad

December 11, 2025

ProPharma Expands Operations with New Office in Hyderabad

ProPharma expands with a new office in Hyderabad, enhancing innovation and growth in regulatory, clinical, and compliance services for the life sciences industry.

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

December 4, 2025

ProPharma Welcomes Dan Ryan as President of Clinical Research Solutions

ProPharma taps Daniel Ryan as President of Clinical Research Solutions, strengthening its clinical trial management leadership and expanding its FSP Solutions.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Overcoming Operational Hurdles in a High-Stakes Stroke Trial - ProPharma

December 15, 2025

Overcoming Operational Hurdles in a High-Stakes Stroke Trial

Argenica Therapeutics’ Phase 2 acute ischaemic stroke trial faced the challenges of unpredictable patient presentation, narrow treatment windows, and demanding emergency care environments. This...

Article Functional Service Provider: An Emerging Paradigm in Clinical Trial Management - ProPharma

November 24, 2025

Functional Service Provider: An Emerging Paradigm in Clinical Trial Management

As biopharma and device companies face workforce reductions, global site expansion, and increasingly intricate clinical protocols, traditional outsourcing models often fall short. The cost of...

Article Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption - ProPharma

November 7, 2025

Tariff Tensions: How Pharma Can Prepare for Supply Chain & Cost Disruption

U.S. tariff policies are shifting fast and pharma companies dependent on global supply chains are feeling the strain. With new tariffs on APIs, excipients, and finished drug products climbing as high...

Previous Resource Arrow Next Resource Arrow
Cracking the Code – Successfully Delivering a Technology Transfer Project

January 20, 2026

Cracking the Code – Successfully Delivering a Technology Transfer Project

In this power-packed webinar, we’ll demystify technology transfer and show why it’s one of the most strategic and risk-sensitive steps in pharmaceutical and biotech operations. You’ll uncover insider...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

Previous Webinar Arrow Next Webinar Arrow